title: Accurate assessment of systemic iron status in cystic fibrosis will avoid the hazards of inappropriate iron supplementation.
authors.forename: D J
authors.initials: DJ
authors.lastname: Smith
authors.forename: G J
authors.initials: GJ
authors.lastname: Anderson
authors.forename: I L
authors.initials: IL
authors.lastname: Lamont
authors.forename: P
authors.initials: P
authors.lastname: Masel
authors.forename: S C
authors.initials: SC
authors.lastname: Bell
authors.forename: D W
authors.initials: DW
authors.lastname: Reid
mesh_terms: D018798:Anemia, Iron-Deficiency / Q000188:drug therapy*; D003550:Cystic Fibrosis / Q000188:drug therapy*; D005290:Ferric Compounds / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology*; D008171:Lung Diseases / Q000139:chemically induced*; D008320:Maltose / Q000031:analogs & derivatives*
chemical_list: D005290:Ferric Compounds; D008320:Maltose